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Abstract
The human erythrocyte anion exchanger (band 3) contains a cytoplasmic domain (cdb3) that exists in a reversible, pH-
dependent structural equilibrium among three native conformations. To understand how this conformational equilibrium
might influence the association state of band 3, we have incubated stripped erythrocyte membranes in solutions ranging from
pH 6.0 to pH 10.5 and have examined the oligomeric state of the protein by size exclusion high performance liquid
chromatography. We demonstrate that incubation of membranes in slightly acidic conditions favors dimer formation,
whereas extended incubation at higher pHs (pHs 9) leads to irreversible formation of an oligomeric species larger than the
tetramer. Since the pH dependence of the conformational state of the cytoplasmic domain exhibits a similar pH profile, we
suggest that the conformation of the cytoplasmic domain can modulate the self-association of band 3. Importantly, this
modulation would appear to require the structural interactions present within the intact protein, since the isolated
membrane-spanning domain does not display any pH dependence of association. The irreversible nature of the alkali-
induced aggregation further suggests that a secondary reaction subsequent to band 3 association is required to stabilize the
high molecular weight aggregate. Although we were able to eliminate covalent bond formation in this irreversible
aggregation process, the exact nature of the secondary reaction remains to be elucidated. ß 2001 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Band 3 (MrV101 000) is the predominant poly-
peptide of the human erythrocyte membrane, com-
prising V25% of the total membrane protein. Mild
proteolytic cleavage of erythrocyte band 3 at the cy-
toplasmic surface of the membrane yields two major
structural domains, a 58-kDa carboxyl-terminal
membrane domain that may traverse the bilayer up
to 14 times [1,2], and a 43-kDa cytosolic amino-ter-
minal domain [3]. The carboxyl-terminal membrane
domain catalyzes the electroneutral exchange of bi-
carbonate for chloride [4^6] and is the major antigen
responsible for immune-mediated removal of senes-
cent and abnormal erythrocytes [7^11]. The cytoplas-
mic domain (cdb3) binds peripheral proteins to the
membrane, including several glycolytic enzymes
[12,13], protein 4.1 [14,15], protein 4.2 [16,17], hemo-
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globin [18,19], hemichromes [20], and ankyrin [21], a
protein that provides the major link of the spectrin-
based membrane skeleton to the bilayer through its
interaction with cdb3. The crystal structure of cdb3
has recently been determined at 2.6 Aî resolution and
reveals that the protein forms a tight symmetric
dimer stabilized by extensive interactions within an
intermonomeric dimerization domain [22]. In addi-
tion, each monomer of cdb3 contains a peripheral
protein binding domain that serves as an anchoring
site for the aforementioned membrane-associated
proteins.
Like many other transmembrane proteins, band 3
is able to self-associate in situ. Most investigators
agree that band 3 exists as a mixture of dimers and
tetramers in the membrane [23^28]. However, some
laboratories report a large predominance of stable
dimers [29,30], while others observe a self-associating
mixture of monomers, dimers, and tetramers [31^33],
or dimers and hexamers [34]. This state of associa-
tion is not unimportant to erythrocyte integrity, since
it can potentially in£uence several critical membrane
functions. For example, band 3 dimers may be the
minimum stable structural unit required for anion
transport [35], and dimers may contribute dispropor-
tionately to the binding and immobilizing of mem-
brane lipid [36], a property thought to be important
to maintenance of membrane shape and stability [37].
In contrast, tetrameric band 3 may stabilize less
membrane lipid, but simultaneously provide the es-
sential anchor for the spectrin-based membrane skel-
eton [23,26,27,38], a structure also believed to be
critical to membrane stability [39]. In addition, high-
er oligomeric forms of band 3 can exist and are im-
portant for the recognition and removal of senescent
cells from circulation [7^11].
Because the association state of band 3 exerts an
impact on membrane function, several investigators
have undertaken to examine factors that might con-
trol this subunit association equilibrium. Those fac-
tors identi¢ed to date include: (i) association with
ankyrin [26,27,38], (ii) the binding of denatured he-
moglobin [40], (iii) oxidative stress [10,11,41], (iv) the
interaction of band 3 with divalent cations and
cationic compounds [9,28,42,43], (v) treatment of
the membrane with hydrophobic agents [9,44],
(vi) DIDS labeling [25,26,45], (vii) temperature [46],
(viii) pH [23,33,47], (ix) underglycosylation [48] and
(x) deletion of amino acids 400^408 (southeast Asian
ovalocytosis) [49]. Since we and others have shown
that cdb3 can exist in three native, pH-dependent
conformations that interconvert at mid pHs of 7.2
and 9.2 [3,50^53], we have wondered whether this
conformational equilibrium might also a¡ect the as-
sociation state of band 3. Unfortunately, the only
data available on the pH dependence of band 3 as-
sociation have been collected below pH 6.5 and near
pH 12, where band 3 is reported to aggregate
[23,33,54]. In fact, the only suggestion that the con-
formational equilibrium in cdb3 might regulate band
3 oligomerization derives from the observation that
the pH dependence of this conformational equilibri-
um follows the pH dependence of ankyrin binding,
where the ankyrin interaction converts from high
a⁄nity to low a⁄nity at a mid pH of 7.2 and from
a low a⁄nity to no a⁄nity at mid pH 9.2 [55]. Since
most labs agree that ankyrin preferentially associates
with tetrameric band 3 [23,26,27,38], it can be hy-
pothesized that the band 3 tetramer might predom-
inate at low pH.
In the present study, we have evaluated the asso-
ciation state of band 3 in stripped erythrocyte mem-
branes incubated at various pHs between 6.0 and
10.5 using size exclusion high performance liquid
chromatography (SE-HPLC). We report that incuba-
tion of membranes at pH6 7.2 favors dimer forma-
tion, whereas extended incubation of band 3 at
pHss 9 leads to irreversible formation of an oligo-
meric species larger than the tetramer. Surprisingly,
at no pH do we observe a reversible shift to-
wards band 3 tetramers in the absence of ankyrin
addition.
2. Materials and methods
2.1. Materials
Human blood was collected from healthy donors
into acid citrate dextrose upon informed consent and
used within 2 days. Materials were purchased from
the following suppliers: octaethylene glycol monodo-
decyl ether (C12E8), Nikko Chemical Co., Tokyo,
Japan; G-4000SWXL SE-HPLC column, Toso-
BBAMEM 78160 28-9-01
M.P. Rettig et al. / Biochimica et Biophysica Acta 1515 (2001) 72^81 73
Haas, Montgomeryville, PA, USA; protein A,
Pierce, Rockford, IL, USA; and Stokes radius cali-
bration standards, Pharmacia, Peapack, NJ, USA.
All other reagents were from major suppliers and
of the highest purity available.
2.2. Preparation of KI-IOVs (1 M KI-stripped
inside-out membrane vesicles)
KI-IOVs were prepared from fresh blood as de-
scribed previously [26]. Brie£y, red cells were washed
and ghosts were prepared by hypotonic lysis in 5 mM
sodium phosphate, 1 mM ethylenediaminetetraacetic
acid (EDTA), pH 8.0 in the presence of 40 Wg/ml
phenylmethylsulfonyl £uoride (PMSF), 2 Wg/ml
leupeptin, and 2 Wg/ml pepstatin A (lysis bu¡er).
The lysate was centrifuged at 23 400Ug for 20 min
and the supernatant was removed. The membrane
pellets were resuspended and washed three additional
times in lysis bu¡er. The white ghosts were then re-
suspended in a 100-fold volume excess of bu¡er con-
taining 0.5 mM EDTA, 0.5 mM dithiothreitol
(DTT), 40 Wg/ml PMSF, pH 8.0, at 4‡C, warmed
to 37‡C over 30 min, and pelleted at 23 400Ug for
30 min to remove spectrin and actin. The remaining
peripheral proteins were removed by incubation for
30 min at 37‡C in a 100-fold excess of 1 M KI, 25
mM sodium phosphate, 1 mM EDTA, 0.5 mM DTT,
40 Wg/ml PMSF, pH 7.5. The resulting KI-IOVs were
pelleted for 30 min at 24 300Ug, then washed twice
with 5 mM sodium phosphate, 1 mM EDTA, pH
8.0, supplemented with 0.5 mM DTT, and stored
at a protein concentration of V2 mg/ml in the
wash bu¡er at 4‡C. Membranes were used within
2 days and protein content was determined by the
bicinchoninic acid method (Pierce).
KI-IOVs containing only the membrane-spanning
domain of band 3 were prepared by treating ghost
membranes (V2 mg/ml) with 5 Wg/ml trypsin, as
described previously [56]. After a 1 h incubation at
0‡C, 1 mM PMSF was added to the membrane sus-
pension and incubation was continued at 0‡C for an
additional 15 min. The treated membranes were then
pelleted by centrifugation at 23 400Ug for 20 min
and washed two additional times in lysis bu¡er.
Trypsin-treated KI-IOVs (tKI-IOVs) were prepared
from the pelleted ghosts, as described above.
2.3. SE-HPLC of band 3 extracted from KI-IOVs by
C12E8
KI-IOVs were incubated at di¡erent pHs by dilut-
ing a stock solution of membranes into 50 mM so-
dium phosphate, 50 mM boric acid, 30 mM NaCl,
1 mM EDTA, 0.5 mM DTT, 10 mM 2-mercaptoeth-
anol, 40 Wg/ml PMSF, 2 Wg/ml leupeptin, 2 Wg/ml
pepstatin A, 0.01% (w/v) sodium azide (bu¡er A)
preadjusted to the desired pH. The ¢nal membrane
protein concentration was 0.16 mg/ml in all cases.
After the desired incubation period at 37‡C, the
KI-IOVs were pelleted by centrifugation at
24 300Ug for 15 min at 4‡C and washed twice with
5 mM sodium phosphate, 1 mM EDTA, pH 8.0
(wash bu¡er) supplemented with 0.5 mM DTT and
2.5 mM 2-mercaptoethanol. The pelleted membranes
were then diluted to V2 mg/ml with wash bu¡er,
and solubilized by vortexing with an equal volume
of 2% C12E8 in wash bu¡er. After a 15 min incuba-
tion on ice, the samples were centrifuged at
43 000Ug for 30 min to remove any residual particles
and analyzed by HPLC.
To determine if the alkali-induced changes in band
3 association state were reversible, KI-IOVs were al-
lowed to equilibrate at 37‡C in bu¡er A adjusted to
pH 9.5. After 24 h at pH 9.5, the membranes were
pelleted by centrifugation at 23 400Ug and washed
with bu¡er A adjusted to either pH 6.5 or 9.5. The
washed membranes were then resuspended in bu¡er
A adjusted to either pH 6.5 or 9.5 and placed back at
37‡C. At various times, membranes were collected,
washed, extracted with C12E8 as described above,
and analyzed by HPLC.
SE-HPLC of solubilized band 3 (V20 Wl) was per-
formed at room temperature at a £ow rate of 0.5 ml/
min, as described by Casey and Reithmeier [23], ex-
cept the column used was a 7.5U300 mm Toso-Haas
TSK-4000SWXL. The column bu¡er was 5 mM so-
dium phosphate, 100 mM NaCl, 0.1% C12E8, pH 7.0
and protein elution was monitored at 215 nm. The
column was calibrated with protein standards, and
band 3 dimer, tetramer, and oligomer elution peaks
were assigned according to the method of Casey and
Reithmeier [23]. To allow comparison among the
di¡erent pH samples, each chromatogram was nor-
malized to one absorbance unit by dividing the ab-
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sorbance from each data point by the largest absor-
bance obtained in the chromatogram.
2.4. Immunoblotting of SE-HPLC fractions
To accurately identify the elution positions of the
band 3 oligomers in the SE-HPLC analyses, 30 sec-
ond fractions of column eluate were collected, ad-
justed to 1% (w/v) sodium dodecyl sulfate (SDS),
and dot-blotted (4 Wl) onto nitrocellulose mem-
branes. Dot-blots were blocked overnight with 5%
milk in TBS-T (20 mM Tris, pH 7.5, 200 mM
NaCl, 0.1% polyethylene glycol, 0.05% Tween 20).
To develop, the blots were then washed with TBS-
T and incubated at room temperature for 3 h in a
solution containing rabbit anti-cdb3 diluted 1/2000 in
TBS-T with 1% milk. After further washing, the dot-
blots were incubated overnight with 0.05 ng/Wl 125I-
labeled protein A diluted in TBS-T with 1% milk.
Iodination of protein A was conducted as previously
described [57]. To quantitate, blots were exposed
overnight to a phosphor screen and imaged using a
Cyclone Storage Phosphor System (Packard Instru-
ment Company; Downers Grove, IL, USA). The
number of digital light units (DLU) per mm2 was
determined for each fraction using the OptiQuant
software. To allow comparison between the di¡erent
pH samples, each chromatogram was normalized to
1 DLU/mm2 by dividing the DLU/mm2 from each
fraction by the largest DLU/mm2 obtained in the
chromatogram.
3. Results
3.1. E¡ect of pH on the oligomeric state of band 3
It has previously been demonstrated that the cyto-
plasmic domain of band 3 (cdb3) exists in a revers-
ible, pH-dependent conformational equilibrium char-
acterized by a V20% increase in the Stokes radius as
pH is elevated from 6.5 to 9.5 [52]. To determine
whether this pH-dependent conformational equilibri-
um might in£uence the association state of band 3 in
situ, we analyzed the oligomerization states of band
3 in KI-IOVs using SE-HPLC. As previously noted
[23,26], band 3 extracted from freshly prepared KI-
IOVs with the non-ionic detergent C12E8 elutes as a
Fig. 1. SE-HPLC analysis of C12E8 detergent extracts of KI-
IOVs incubated at di¡erent pHs. KI-IOVs were allowed to
equilibrate for 24 h at 37‡C in 50 mM sodium phosphate, 50
mM boric acid, 30 mM NaCl, 1 mM EDTA, 0.5 mM DTT, 10
mM 2-mercaptoethanol, 40 Wg/ml PMSF, 2 Wg/ml leupeptin,
2 Wg/ml pepstatin A, and 0.01% (w/v) sodium azide at the desired
pH. Membranes were then extracted with 2% C12E8 and centri-
fuged at 43 000Ug for 30 min. Supernatants were collected and
analyzed by SE-HPLC using a TSK-4000SWXL column. The
elution bu¡er contained 5 mM sodium phosphate, 100 mM
NaCl, 0.1% C12E8, pH 7.0, and protein elution was monitored
at 215 nm (solid lines). In addition, fractions (0.25 ml) of
eluant were collected, and band 3 content was determined by
immunoblotting as described in Section 2 (dotted lines). The
top chromatogram (labeled KI-IOV) served as a control and
represents the elution pro¢le obtained from KI-IOVs that were
kept on ice at pH 8.0 during the 24 h incubation. Shown on
the x axis are the elution positions of the following protein
standards: T, thyroglobulin (RS = 86 Aî ); F, ferritin (RS = 63
Aî ); C, catalase (RS = 52 Aî ); and A, aldolase (RS = 46 Aî ). The
void volume (V0) was determined from the elution position of
blue dextran 2000 (average Mr = 2U106).
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mixture of dimers, tetramers and higher oligomers
(Fig. 1, KI-IOV chromatogram). In further agree-
ment with the characterization of Casey and Reith-
meier [23], the band 3 dimer exhibits a Stokes radius
of V76 Aî (elution volume = 8.7 ml) and the tetramer
a Stokes radius of V100 Aî (elution volume = 7.8
ml). Importantly, the distribution of band 3 oligo-
meric species observed in Fig. 1 re£ects the state of
the protein prior to solubilization [23]. Therefore,
SE-HPLC of C12E8 detergent extracts is an e¡ective
method for evaluating alterations in the oligomeric
state of band 3 in situ.
Fig. 1 also includes chromatographic pro¢les ob-
tained from KI-IOVs incubated for 24 h at 37‡C in
solutions ranging from pH 6.5 to pH 9.5 (solid lines).
Increasing the solution pH over this range results in
a decrease in the amount of band 3 dimer and tet-
ramer with a concomitant appearance of several ag-
gregated complexes eluting between 6 and 7 ml. To
con¢rm that these larger oligomers are indeed band
3, we collected the various fractions of eluate and
performed quantitative immunoblots for the presence
of band 3. As shown in the ¢gure (dotted lines), this
analysis con¢rms that the aggregated complexes in-
deed contain band 3 and that their emergence at
elevated pHs proceeds with a concomitant decrease
in the amount of band 3 dimer and tetramer. In
addition, the immunoblot of the pH 9.5-treated sam-
ple reveals a nearly complete conversion of all band 3
to forms larger than the dimer. Interestingly, the re-
sidual peak still present at the dimer position in this
pH 9.5 elution pro¢le (solid line) is not band 3.
While the proteins present in this fraction have not
been fully examined, immunoblot analysis suggests
that at least one component must be glycophorin A
(data not shown).
In addition to the formation of novel aggregated
species following incubation at higher pH; there were
three further alterations in the chromatographic
properties of band 3 as a function of pH. First, in-
cubation of KI-IOVs in slightly acidic conditions
(pH 6.5) consistently yielded less high molecular
weight oligomer and less tetramer than control (KI-
IOV) and pH 7.5-treated membranes. This observa-
tion suggests that the hydrodynamically more com-
pact form of cdb3 occurring at pH 6.5 may somehow
favor dimer formation, in contrast to our initial hy-
pothesis. Second, the sharply resolved dimer and tet-
ramer peaks seen in the elution pro¢le at pH 7.5
gradually convert to a species of intermediate mobil-
ity (eluting between the dimer and tetramer) as the
pH is increased to 9.0. We assume this implies either
the formation of a trimer, the rapid interconversion
of dimers and tetramers, or the partial unfolding of
the dimer, leading to a conformation characterized
by a larger hydrodynamic volume. Further studies
will obviously be necessary to evaluate these possi-
bilities more rigorously. Finally, there was a slight
increase in the amount of oligomeric band 3 species
eluting at the void volume as the pH was increased
from 6.5 to 9.5. That is, a component even larger
than the above oligomer eluting between 6 and 7
ml also increases at high pH. The nature of this
aggregate has not been investigated.
3.2. Quantitation of the pH-dependent change in
band 3 subunit association
To quantitate the observed shift in band 3 associ-
ation state as a function of pH, the percent dimer in
Fig. 2. Dependence of band 3 dimer content on incubation pH.
KI-IOV samples were treated and analyzed as detailed in Fig.
1. Results are expressed as the percent dimer relative to the to-
tal band 3 content in each sample (solid line), as determined
from the integrated areas under the peaks in each chromato-
gram. The dimer area was integrated from 8.23 ml to 9.52 ml
and the total band 3 area was integrated from 5.00 ml to 9.52
ml. The non-band 3 contribution to the dimer peak, obtained
from the pH 9.5 analysis, was subtracted in all cases. Data col-
lected at pHs 6.5, 7.5, 8.5, 9.0, and 9.5 represent the mean þ
1 S.D. of ¢ve experiments on separate KI-IOV preparations.
The data collected at pH 6.0 and 10.5 represent the average of
three chromatographs conducted on a single KI-IOV prepara-
tion. The pH-dependent change in cdb3’s Stokes radius (dashed
line) was re-plotted from the data in [52].
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each chromatogram (Fig. 1, solid lines) was calcu-
lated from the corrected areas under the dimer
peak (integrated from 8.23 ml to 9.52 ml) relative
to the total band 3 area (integrated from 5.00 ml
to 9.52 ml) in each chromatogram. For correction
of the band 3 dimer content, the contribution of
the non-band 3 species eluting at pH 9.5 was sub-
tracted from each chromatogram, based on the dot-
blots shown in Fig. 1. As seen in Fig. 2, the observed
pH dependence of dimer content is triphasic, with
the dimer favored at low pH and larger oligomers
favored at high pH. Although insu⁄cient data have
been collected to determine the pKa of the two in-
£ection points, the shape of the curve still resembles
the previously published titration curve of the con-
formational change in cdb3, as indicated by the
change in Stokes radius [52]. This correlation sug-
gests that the conformation of cdb3 may in£uence
the association state of band 3 in situ. More specif-
ically, the compact form of cdb3 that occurs under
slightly acidic conditions may favor dimer formation,
whereas the elongated state of cdb3, induced by al-
kaline treatment, may allow formation of oligomeric
species larger than the tetramer. No treatment iden-
ti¢ed to date, except the addition of ankyrin
[23,26,27,38], appears to favor tetramer formation.
3.3. Kinetics of the pH-dependent change in band 3
subunit association
The SE-HPLC pro¢les in Fig. 1 show that conver-
sion of band 3 dimers to higher oligomers at pH 9.5
is complete by 24 h. The kinetics of this change in
band 3 association at pH 9.5 and pH 6.5 are shown
in Fig. 3. Freshly prepared KI-IOVs (at pH 8.0) con-
taining approximately 45% dimer (Fig. 3, t = 0 h)
were diluted into solutions of pH 9.5 or pH 6.5
and incubated at 37‡C. At the indicated time points,
an aliquot of each suspension was processed and
analyzed by HPLC, as described in Section 2. As
shown in the ¢gure, incubation of KI-IOVs at pH
9.5 led to complete disappearance of the dimer and
its conversion to higher oligomers with a half time of
V4 h. Also shown is a rapid V18% increase in the
amount of dimer at the expense of tetramer within
the ¢rst hour of the incubation at pH 6.5. During the
remaining 23 h, there was only an additional V7%
increase in the amount of dimer. These data support
the hypothesis that the more compact form of cdb3
occurring at low pH favors the band 3 dimer, where-
as the elongated form of cdb3 at pH 9.5 allows band
3 aggregation.
3.4. E¡ect of pH on association of the
membrane-spanning domain of band 3
As mentioned above, erythrocyte band 3 contains
two major structural domains, a 58-kDa carboxyl-
terminal membrane domain and a 43-kDa amino-
terminal cytosolic domain. To determine how each
domain individually contributes to the pH-dependent
changes in band 3 association state, we removed
cdb3 from the KI-IOVs with trypsin and evaluated
the e¡ect of pH on the association state of the mem-
brane-spanning domain. In agreement with previous
reports [23,58], the membrane-spanning domain ex-
tracted from the trypsinized KI-IOVs migrated al-
most exclusively as a dimer in C12E8 detergent solu-
tion (Fig. 4, tKI-IOV chromatogram). Further, prior
incubation of the trypsinized KI-IOVs for 24 h at
Fig. 3. Time dependence of the change in band 3 association
state during incubation of KI-IOVs at pH 6.5 and 9.5. KI-
IOVs were equilibrated at 37‡C in 50 mM sodium phosphate,
50 mM boric acid, 30 mM NaCl, 1 mM EDTA, 0.5 mM DTT,
10 mM 2-mercaptoethanol, 40 Wg/ml PMSF, 0.2 Wg/ml leupep-
tin, 0.2 Wg/ml pepstatin A, 0.01% sodium azide adjusted to ei-
ther pH 6.5 (a) or 9.5 (b). At the indicated time points, the
membranes were extracted and analyzed by SE-HPLC, as de-
tailed in Fig. 1. The percent dimer in each chromatogram was
determined from the integrated area under the peaks, as de-
scribed in Fig. 2. Each point represents the mean þ 1 S.D. of
three experiments on separate KI-IOV preparations.
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37‡C in solutions ranging from pH 6.5 to pH 9.5
yielded no change in oligomeric species (Fig. 4).
There was a slight increase in the amount of band
3 eluting at the void volume as the pH was increased
from 6.5 to 9.5. However, since the quantity of this
aggregated protein at pH 9.5 was always less than
2% of the total protein analyzed, we conclude that
the alkali-induced aggregation of band 3 is not driv-
en by a tendency of the membrane-spanning domain
to associate at high pH.
3.5. Reversibility of the alkali-induced association of
band 3
To evaluate whether the band 3 oligomerization
seen in situ at high pH re£ects a possible regulatory
equilibrium within the band 3 population, we ex-
plored the natural reversibility of this interaction.
For this purpose, alkali-induced oligomers were gen-
erated by incubating KI-IOVs for 24 h at 37‡C in pH
9.5 bu¡er and then re-incubating the KI-IOVs at
either pH 6.5 or 9.5 prior to solubilization in C12E8
detergent. We found that resuspension of the pH 9.5-
treated KI-IOVs into a pH 6.5 solution resulted in
no dissociation of the alkali-induced band 3 oligo-
mers over a 24 h incubation period (data not shown).
Since reducing agents were present during all steps,
the irreversible association of band 3 in KI-IOVs at
pH 9.5 is probably not due to disul¢de bond forma-
tion. In addition, SDS^polyacrylamide gel electro-
phoresis demonstrated that greater than 90% of the
band 3 in the pH 9.5-treated KI-IOVs migrated as a
monomer (data not shown), suggesting that the asso-
ciation was not stabilized by covalent bond forma-
tion. Still, the aggregation was su⁄ciently avid to
prevent dissociation back to dimers within the 24 h
re-equilibration period at pH 6.5.
4. Discussion
In previous research, we have noted that the pH
dependence of ankyrin binding to KI-IOVs corre-
sponds closely to the pH dependence of the confor-
mational equilibrium in cdb3, with both titrations
displaying three structural states characterized by
transitions centered at pHs 7.2 and 9.2 [3,50^53,55].
Since ankyrin strongly prefers to bind the low pH
conformation of cdb3 [55] and the tetrameric form
of intact band 3 [23,26,27,38], we hypothesized that
the low pH conformation might, in fact, promote
tetramer formation in situ. We further speculated
that titration of cdb3 from high pH through the
structural transitions at pHs 9.2 and 7.2 might con-
vert band 3 from a monomer to dimer to tetramer,
respectively. However, in contrast to these expecta-
tions, the conformational equilibrium in cdb3 was
found to correlate only with the stability of the
band 3 dimer (Fig. 2). In fact, the default oligomer
Fig. 4. SE-HPLC analysis of the membrane-spanning domain
of band 3 following incubation of tKI-IOVs at di¡erent pHs.
Red blood cell ghost membranes were treated with trypsin to
remove the cdb3, and KI-IOVs were prepared. The tKI-IOVs
were equilibrated at the indicated pHs for 24 h at 37‡C and an-
alyzed by SE-HPLC as detailed in Fig. 1. A typical result from
two independent experiments is shown.
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formed when the dimer destabilized was not the an-
ticipated tetramer, but rather an irreversible aggre-
gate. These data suggest that the conformational
equilibrium in cdb3 does not function physiologically
to regulate band 3 subunit equilibrium, but rather
may enable cdb3’s participation in some other struc-
ture-dependent process. Candidate processes that
might depend on cdb3’s conformational £exibility
include the formation or optimization of mem-
brane^skeleton interactions, especially since the a⁄n-
ity of ankyrin for KI-IOVs correlates directly with
the conformational state of cdb3 [55]. Alternatively,
since the conformational equilibrium also occurs in
kidney cdb3 [59], which has no a⁄nity for ankyrin or
any other known erythrocyte protein [59,60], the
structural changes may function more to regulate
the membrane-spanning domain of band 3. Further
studies will obviously be necessary to resolve why
cdb3 changes conformation so easily.
The continued inability to identify any solution
condition that can promote band 3 tetramer forma-
tion in situ was not expected, especially since band 3
isolated from freshly prepared KI-IOVs exists as a
mixture of dimers and tetramers [23^28]. Because
band 3 tetramers are not formed in the absence of
ankyrin [38], one is compelled to conclude that an-
kyrin may be the sole driving force for band 3 tetra-
merization in vivo. Still, the fact that such ankyrin-
induced tetramers remain stable for many hours at
4‡C following ankyrin removal [23^25,27,28], and
since they survive for at least 24 h at 37‡C (Fig. 1),
one must surmise that a weak natural a⁄nity exists
to stabilize the dimer^dimer associations once they
are induced. Thus, non-interacting band 3 dimers
should have a di¡usion coe⁄cient of approximately
1039 cm2/s in cytoskeleton-depleted membranes
[61,62], suggesting that any unassociated dimers
would di¡use apart at nearly 1 micron/s (calculated
from the relationship x2 = 2Dt ; where D is 1039 cm2/
s and t is 1 s) if unrestrained by dimer^dimer inter-
actions. The dimer^dimer contacts revealed in the
crystal structure of cdb3 [22] could provide the hy-
pothesized stabilizing interactions required to pro-
long tetramer lifespan in situ.
Although the conformational equilibrium in cdb3
may not serve to regulate band 3 tetramer content,
the correlation between cdb3 conformation and band
3 aggregation in situ (Fig. 2) still suggests that ag-
gregation depends in some way on the structure of
cdb3. Among several possible mechanisms, the most
obvious would have been that cdb3 itself might ag-
gregate in a pH-dependent manner. However, no
stable oligomers of puri¢ed cdb3 have ever been ob-
served upon extended incubation at high pH ([52]
and data not shown). A second conceivable mecha-
nism was that the membrane-spanning domain of
band 3 might spontaneously aggregate in the absence
of cdb3, and that this aggregation would have only
been allowed when cdb3 was titrated to a permissive
(i.e. high pH) conformation. However, once again,
the membrane-spanning domain displayed no dispo-
sition to aggregate at any pH where intact band 3
was seen to associate (Fig. 4). It would, therefore,
seem likely that band 3 aggregation might require
an intact protein, perhaps in a membrane environ-
ment. In this scenario, the conformational change in
cdb3 might be envisioned to force exposure of pre-
viously cryptic aggregation sites in the membrane-
spanning domain, leading to irreversible clustering
of the polypeptide. Interestingly, Salhany et al. re-
cently reported that conformational changes within
the membrane-spanning domain of band 3 induced
the dissociation of band 3 dimers at 37‡C [46]. How-
ever, whether pH-dependent structural changes with-
in cdb3 induce such conformational changes within
the membrane-spanning domain has not been deter-
mined.
Although our results largely con¢rm those of
Vince et al. [54] wherever overlap occurs, one appar-
ent discrepancy warrants further explanation. These
authors observed no band 3 aggregation upon incu-
bation of puri¢ed band 3 in solutions of elevated pH,
while we obviously noted extensive aggregation in
our model system. However, two signi¢cant di¡er-
ences in the methodologies must be considered. First,
Vince et al. incubated their band 3 preparations for
only 1 h before HPLC analysis. As indicated in Fig.
3, we also observed no conversion of band 3 dimer to
oligomer at this short incubation time. Second, the
high pH incubations of Vince et al. were conducted
on detergent-solubilized band 3, not the membrane-
associated polypeptide. Since modeling studies pre-
dict that protein association within a membrane
should be enhanced at least 106-fold relative to the
solubilized counterparts [63], the failure to observe
band 3 aggregation in their study could also be
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caused by the lower protein concentration and/or
absence of rotational and translational restrictions
in the solubilized system.
In summary, regulatory changes in the band 3 sub-
unit association equilibrium do not appear to be con-
trolled by the conformational equilibrium in cdb3,
even though this equilibrium may directly regulate
ankyrin a⁄nity. It now seems more likely that ankyr-
in is solely responsible for band 3 tetramer formation
and that prolonged tetramer survival following an-
kyrin removal is simply a consequence of weak
dimer^dimer interactions that are insu⁄cient to
maintain the tetrameric state inde¢nitely.
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